Automated Sample Storage Systems Market: Why Pharma, Biobanks, and Investors Are Increasing Spending

For most pharmaceutical executives, the biggest challenge is no longer generating biological samples—it is managing them efficiently.

Drug discovery programs, clinical trials, genomics studies, cell therapy development, and biobanking initiatives are producing millions of samples every year. A misplaced sample can delay research, increase costs, or even compromise years of scientific work.

As a result, automated sample storage systems have evolved from laboratory equipment into strategic infrastructure. These systems use robotics, software, artificial intelligence, and ultra-low-temperature storage technologies to automatically store, track, retrieve, and monitor biological and chemical samples with minimal human intervention.

For decision makers, the key question is no longer whether automation is needed, but how quickly organizations can deploy it to support future growth.

Market Growth Is Being Driven by Sample Explosion

Life sciences organizations are generating more samples than ever before.

The global automated sample storage systems market is estimated at approximately $1.42 billion in 2025 and is projected to exceed $4.12 billion by 2035, representing double-digit annual growth.

Several trends are driving demand:

• Growth in precision medicine programs
• Expansion of biobanks worldwide
• Rising genomic sequencing volumes
• Increasing clinical trial activity
• Growth of cell and gene therapy pipelines

Market Snapshot

Why Pharmaceutical Companies Are Investing

Large pharmaceutical companies now manage millions of compounds and biological samples throughout drug development.

A single high-throughput screening campaign can evaluate more than 1 million chemical compounds. Every compound requires secure storage, tracking, retrieval, and quality control.

Manual storage systems create risks such as:

• Sample misidentification
• Human handling errors
• Inventory inaccuracies
• Regulatory compliance issues
• Delayed retrieval times

Automated systems reduce these risks while increasing operational efficiency.

Many global pharmaceutical companies report that automated storage can reduce sample retrieval times from hours to minutes while improving inventory accuracy above 99%.

Biobanks Are Becoming Major Customers

The rise of biobanking is creating a major growth opportunity.

National healthcare systems, cancer research centers, and genomics programs are collecting biological samples on an unprecedented scale.

Large Biobank Examples

Looking for answers to your specific business questions? Our experts provide FREE customized sample reports. Download and get complete market insights you want for FREE: https://www.towardshealthcare.com/download-sample/5370

Managing these collections manually is increasingly impractical.

Automated storage systems enable:

• Long-term preservation
• Digital tracking
• Regulatory compliance
• High-volume retrieval
• Reduced contamination risk

Cell and Gene Therapy Is Creating New Demand

One of the fastest-growing customer groups is the cell and gene therapy industry.

The global cell and gene therapy pipeline now includes more than 4,000 therapies across various stages of development.

These therapies require storage of:

• Patient-derived cells
• Viral vectors
• DNA samples
• RNA materials
• Clinical trial specimens

Many of these materials must be stored at temperatures between -80°C and -196°C, making automation essential for maintaining sample integrity.

What Leading Suppliers Are Offering

Modern automated sample storage vendors are moving beyond simple freezers.

Today’s systems provide:

These capabilities help organizations manage growing sample volumes without proportional increases in staffing costs.

Where Investment Is Going

Manufacturers are investing heavily to expand capacity and improve technology.

Key investment areas include:

Ultra-Low Temperature Storage

Demand for -80°C and cryogenic systems continues to grow as biologics and advanced therapies expand.

AI-Powered Inventory Management

Companies are introducing predictive analytics to optimize storage utilization and reduce retrieval times.

Smart Laboratory Integration

Automated storage platforms are increasingly integrated with:

• Laboratory Information Management Systems (LIMS)
• Electronic Lab Notebooks
• Clinical Trial Platforms
• Quality Management Systems

Sustainability Initiatives

Energy consumption remains a major concern.

New systems are being designed to reduce power usage while maintaining strict temperature requirements.

Challenges Decision Makers Must Consider

Despite strong growth prospects, several challenges remain.

Organizations must balance long-term operational savings against significant upfront investment requirements.

Key Statistics for Executives

Why This Market Matters to Decision Makers

For pharmaceutical executives, biotech investors, laboratory directors, and healthcare leaders, automated sample storage is becoming a critical competitive advantage.

Organizations that can efficiently manage millions of samples will be better positioned to accelerate drug discovery, support precision medicine programs, expand clinical trials, and commercialize advanced therapies.

As genomic data generation, biobanking activity, and cell therapy development continue to grow, automated sample storage systems are likely to become one of the most important enabling technologies across the life sciences industry.